Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Genomic signature of parity in the breast of premenopausal women.

Santucci-Pereira J, Zeleniuch-Jacquotte A, Afanasyeva Y, Zhong H, Slifker M, Peri S, Ross EA, López de Cicco R, Zhai Y, Nguyen T, Sheriff F, Russo IH, Su Y, Arslan AA, Bordas P, Lenner P, Åhman J, Landström Eriksson AS, Johansson R, Hallmans G, Toniolo P, Russo J.

Breast Cancer Res. 2019 Mar 28;21(1):46. doi: 10.1186/s13058-019-1128-x.

2.

The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy.

Liu S, Marneth AE, Alexe G, Walker SR, Gandler HI, Ye DQ, Labella K, Mathur R, Toniolo PA, Tillgren M, Gokhale PC, Barbie D, Mullally A, Stegmaier K, Frank DA.

Blood Adv. 2018 Dec 11;2(23):3428-3442. doi: 10.1182/bloodadvances.2018016733.

3.

Early pregnancy sex steroids during primiparous pregnancies and maternal breast cancer: a nested case-control study in the Northern Sweden Maternity Cohort.

Fortner RT, Tolockiene E, Schock H, Oda H, Lakso HÅ, Hallmans G, Kaaks R, Toniolo P, Zeleniuch-Jacquotte A, Grankvist K, Lundin E.

Breast Cancer Res. 2017 Jul 18;19(1):82. doi: 10.1186/s13058-017-0876-8.

4.

Human Chorionic Gonadotropin Does Not Correlate with Risk for Maternal Breast Cancer: Results from the Finnish Maternity Cohort.

Fortner RT, Schock H, Kaaks R, Lehtinen M, Pukkala E, Lakso HÅ, Tanner M, Kallio R, Joensuu H, Korpela J, Toriola AT, Hallmans G, Grankvist K, Zeleniuch-Jacquotte A, Toniolo P, Lundin E, Surcel HM.

Cancer Res. 2017 Jan 1;77(1):134-141. doi: 10.1158/0008-5472.CAN-16-1524. Epub 2016 Oct 26.

5.

Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent.

Xiang M, Kim H, Ho VT, Walker SR, Bar-Natan M, Anahtar M, Liu S, Toniolo PA, Kroll Y, Jones N, Giaccone ZT, Heppler LN, Ye DQ, Marineau JJ, Shaw D, Bradner JE, Blonquist T, Neuberg D, Hetz C, Stone RM, Soiffer RJ, Frank DA.

Blood. 2016 Oct 6;128(14):1845-1853. doi: 10.1182/blood-2015-07-660506. Epub 2016 Aug 16.

6.

Deregulation of SOCS5 suppresses dendritic cell function in chronic lymphocytic leukemia.

Toniolo PA, Liu S, Yeh JE, Ye DQ, Barbuto JA, Frank DA.

Oncotarget. 2016 Jul 19;7(29):46301-46314. doi: 10.18632/oncotarget.10093.

7.

Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation.

Toniolo PA, Liu S, Yeh JE, Moraes-Vieira PM, Walker SR, Vafaizadeh V, Barbuto JA, Frank DA.

J Immunol. 2015 Apr 1;194(7):3180-90. doi: 10.4049/jimmunol.1401635. Epub 2015 Feb 27.

8.

Dendritic Cell-Derived Exosomes may be a Tool for Cancer Immunotherapy by Converting Tumor Cells into Immunogenic Targets.

Romagnoli GG, Zelante BB, Toniolo PA, Migliori IK, Barbuto JA.

Front Immunol. 2015 Jan 19;5:692. doi: 10.3389/fimmu.2014.00692. eCollection 2014. Review.

9.

Early pregnancy sex steroids and maternal breast cancer: a nested case-control study.

Fortner RT, Schock H, Kaaks R, Lehtinen M, Pukkala E, Lakso HÅ, Tanner M, Kallio R, Joensuu H, Grankvist K, Zeleniuch-Jacquotte A, Toniolo P, Lundin E, Surcel HM.

Cancer Res. 2014 Dec 1;74(23):6958-67. doi: 10.1158/0008-5472.CAN-14-2150. Epub 2014 Oct 3.

10.

Early pregnancy sex steroids and maternal risk of epithelial ovarian cancer.

Schock H, Surcel HM, Zeleniuch-Jacquotte A, Grankvist K, Lakso HÅ, Fortner RT, Kaaks R, Pukkala E, Lehtinen M, Toniolo P, Lundin E.

Endocr Relat Cancer. 2014;21(6):831-44. doi: 10.1530/ERC-14-0282.

11.

Circulating estrogen metabolites and risk of breast cancer in postmenopausal women.

Arslan AA, Koenig KL, Lenner P, Afanasyeva Y, Shore RE, Chen Y, Lundin E, Toniolo P, Hallmans G, Zeleniuch-Jacquotte A.

Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1290-7. doi: 10.1158/1055-9965.EPI-14-0009. Epub 2014 Apr 27.

12.

Free β-human chorionic gonadotropin, total human chorionic gonadotropin and maternal risk of breast cancer.

Toriola AT, Tolockiene E, Schock H, Surcel HM, Zeleniuch-Jacquotte A, Wadell G, Toniolo P, Lundin E, Grankvist K, Lukanova A.

Future Oncol. 2014 Feb;10(3):377-84. doi: 10.2217/fon.13.208.

13.

JAK2-STAT5 signaling: A novel mechanism of resistance to targeted PI3K/mTOR inhibition.

Yeh JE, Toniolo PA, Frank DA.

JAKSTAT. 2013 Oct 1;2(4):e24635. doi: 10.4161/jkst.24635. Epub 2013 Apr 15.

14.

Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.

Liu S, Walker SR, Nelson EA, Cerulli R, Xiang M, Toniolo PA, Qi J, Stone RM, Wadleigh M, Bradner JE, Frank DA.

Mol Cancer Ther. 2014 May;13(5):1194-205. doi: 10.1158/1535-7163.MCT-13-0341. Epub 2014 Jan 16.

15.

Targeting transcription factors: promising new strategies for cancer therapy.

Yeh JE, Toniolo PA, Frank DA.

Curr Opin Oncol. 2013 Nov;25(6):652-8. doi: 10.1097/01.cco.0000432528.88101.1a. Review.

PMID:
24048019
16.

Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.

Scarmo S, Afanasyeva Y, Lenner P, Koenig KL, Horst RL, Clendenen TV, Arslan AA, Chen Y, Hallmans G, Lundin E, Rinaldi S, Toniolo P, Shore RE, Zeleniuch-Jacquotte A.

Breast Cancer Res. 2013 Feb 26;15(1):R15. doi: 10.1186/bcr3390.

17.

Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies.

Eliassen AH, Hendrickson SJ, Brinton LA, Buring JE, Campos H, Dai Q, Dorgan JF, Franke AA, Gao YT, Goodman MT, Hallmans G, Helzlsouer KJ, Hoffman-Bolton J, Hultén K, Sesso HD, Sowell AL, Tamimi RM, Toniolo P, Wilkens LR, Winkvist A, Zeleniuch-Jacquotte A, Zheng W, Hankinson SE.

J Natl Cancer Inst. 2012 Dec 19;104(24):1905-16. doi: 10.1093/jnci/djs461. Epub 2012 Dec 6.

18.

Defining the genomic signature of the parous breast.

Peri S, de Cicco RL, Santucci-Pereira J, Slifker M, Ross EA, Russo IH, Russo PA, Arslan AA, Belitskaya-Lévy I, Zeleniuch-Jacquotte A, Bordas P, Lenner P, Åhman J, Afanasyeva Y, Johansson R, Sheriff F, Hallmans G, Toniolo P, Russo J.

BMC Med Genomics. 2012 Oct 11;5:46. doi: 10.1186/1755-8794-5-46.

19.

Methylation signature of lymph node metastases in breast cancer patients.

Barekati Z, Radpour R, Lu Q, Bitzer J, Zheng H, Toniolo P, Lenner P, Zhong XY.

BMC Cancer. 2012 Jun 13;12:244. doi: 10.1186/1471-2407-12-244.

20.

Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer.

Lundin E, Wirgin I, Lukanova A, Afanasyeva Y, Krogh V, Axelsson T, Hemminki K, Clendenen TV, Arslan AA, Ohlson N, Sieri S, Roy N, Koenig KL, Idahl A, Berrino F, Toniolo P, Hallmans G, Försti A, Muti P, Lenner P, Shore RE, Zeleniuch-Jacquotte A.

Cancer Epidemiol. 2012 Oct;36(5):445-52. doi: 10.1016/j.canep.2012.04.006. Epub 2012 May 25.

21.

Premenopausal serum androgens and breast cancer risk: a nested case-control study.

Zeleniuch-Jacquotte A, Afanasyeva Y, Kaaks R, Rinaldi S, Scarmo S, Liu M, Arslan AA, Toniolo P, Shore RE, Koenig KL.

Breast Cancer Res. 2012 Feb 16;14(1):R32.

22.

Mutations of mitochondrial DNA as potential biomarkers in breast cancer.

Cai FF, Kohler C, Zhang B, Chen WJ, Barekati Z, Garritsen HS, Lenner P, Toniolo P, Zhang JJ, Zhong XY.

Anticancer Res. 2011 Dec;31(12):4267-71.

PMID:
22199290
23.

Pregnancy-induced chromatin remodeling in the breast of postmenopausal women.

Russo J, Santucci-Pereira J, de Cicco RL, Sheriff F, Russo PA, Peri S, Slifker M, Ross E, Mello ML, Vidal BC, Belitskaya-Lévy I, Arslan A, Zeleniuch-Jacquotte A, Bordas P, Lenner P, Ahman J, Afanasyeva Y, Hallmans G, Toniolo P, Russo IH.

Int J Cancer. 2012 Sep 1;131(5):1059-70. doi: 10.1002/ijc.27323. Epub 2012 Jan 3.

24.

Determinants of maternal sex steroids during the first half of pregnancy.

Toriola AT, Vääräsmäki M, Lehtinen M, Zeleniuch-Jacquotte A, Lundin E, Rodgers KG, Lakso HA, Chen T, Schock H, Hallmans G, Pukkala E, Toniolo P, Grankvist K, Surcel HM, Lukanova A.

Obstet Gynecol. 2011 Nov;118(5):1029-36. doi: 10.1097/AOG.0b013e3182342b7f. Erratum in: Obstet Gynecol. 2012 Jan;119(1):186-7.

25.

Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer.

Zeleniuch-Jacquotte A, Shore RE, Afanasyeva Y, Lukanova A, Sieri S, Koenig KL, Idahl A, Krogh V, Liu M, Ohlson N, Muti P, Arslan AA, Lenner P, Berrino F, Hallmans G, Toniolo P, Lundin E.

Br J Cancer. 2011 Oct 25;105(9):1458-64. doi: 10.1038/bjc.2011.381. Epub 2011 Sep 27.

26.

Insulin-like growth factor-I and C-reactive protein during pregnancy and maternal risk of non-epithelial ovarian cancer: a nested case-control study.

Toriola AT, Surcel HM, Lundin E, Schock H, Grankvist K, Pukkala E, Chen T, Toniolo P, Lehtinen M, Zeleniuch-Jacquotte A, Lukanova A.

Cancer Causes Control. 2011 Nov;22(11):1607-11. doi: 10.1007/s10552-011-9828-2. Epub 2011 Aug 11.

PMID:
21833488
27.

Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies.

Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, Reeves GK, Roddam AW, Helzlsouer KJ, Alberg AJ, Rollison DE, Dorgan JF, Brinton LA, Overvad K, Kaaks R, Trichopoulou A, Clavel-Chapelon F, Panico S, Duell EJ, Peeters PH, Rinaldi S, Fentiman IS, Dowsett M, Manjer J, Lenner P, Hallmans G, Baglietto L, English DR, Giles GG, Hopper JL, Severi G, Morris HA, Hankinson SE, Tworoger SS, Koenig K, Zeleniuch-Jacquotte A, Arslan AA, Toniolo P, Shore RE, Krogh V, Micheli A, Berrino F, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Lui LY, Cummings SR, Gunter MJ, Rohan TE, Strickler HD.

Br J Cancer. 2011 Aug 23;105(5):709-22. doi: 10.1038/bjc.2011.254. Epub 2011 Jul 19.

28.

Assessing the value of CAN-gene mutations using MALDI-TOF MS.

Kohler C, Tavelin B, Fan AX, Radpour R, Barekati Z, Levi F, Zhong XY, Lenner P, Toniolo P.

J Cancer Res Clin Oncol. 2011 Aug;137(8):1239-44. doi: 10.1007/s00432-011-0990-4. Epub 2011 Jun 21.

PMID:
21691751
29.

Circulating insulin-like growth factor-I in pregnancy and maternal risk of breast cancer.

Toriola AT, Lundin E, Schock H, Grankvist K, Pukkala E, Chen T, Zeleniuch-Jacquotte A, Toniolo P, Lehtinen M, Surcel HM, Lukanova A.

Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1798-801. doi: 10.1158/1055-9965.EPI-11-0441. Epub 2011 Jun 15.

30.

Characterization of a genomic signature of pregnancy identified in the breast.

Belitskaya-Lévy I, Zeleniuch-Jacquotte A, Russo J, Russo IH, Bordás P, Ahman J, Afanasyeva Y, Johansson R, Lenner P, Li X, de Cicco RL, Peri S, Ross E, Russo PA, Santucci-Pereira J, Sheriff FS, Slifker M, Hallmans G, Toniolo P, Arslan AA.

Cancer Prev Res (Phila). 2011 Sep;4(9):1457-64. doi: 10.1158/1940-6207.CAPR-11-0021. Epub 2011 May 27.

31.

Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer.

Lukanova A, Surcel HM, Lundin E, Kaasila M, Lakso HA, Schock H, Husing A, Kaaks R, Koskela P, Grankvist K, Pukkala E, Zeleniuch-Jacquotte A, Lehtinen M, Toniolo P.

Int J Cancer. 2012 Feb 15;130(4):910-20. doi: 10.1002/ijc.26070. Epub 2011 May 9.

32.

Endogenous hormones and coronary heart disease in postmenopausal women.

Chen Y, Zeleniuch-Jacquotte A, Arslan AA, Wojcik O, Toniolo P, Shore RE, Levitz M, Koenig KL.

Atherosclerosis. 2011 Jun;216(2):414-9. doi: 10.1016/j.atherosclerosis.2011.01.053. Epub 2011 Mar 1.

33.

Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancer.

Chen T, Surcel HM, Lundin E, Kaasila M, Lakso HA, Schock H, Kaaks R, Koskela P, Grankvist K, Hallmans G, Pukkala E, Zeleniuch-Jacquotte A, Toniolo P, Lehtinen M, Lukanova A.

Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):324-36. doi: 10.1158/1055-9965.EPI-10-0857. Epub 2010 Dec 21.

34.

Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer.

Kim DH, Smith-Warner SA, Spiegelman D, Yaun SS, Colditz GA, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Harnack L, Jacobs EJ, Leitzmann M, Mannisto S, Miller AB, Potter JD, Rohan TE, Schatzkin A, Speizer FE, Stevens VL, Stolzenberg-Solomon R, Terry P, Toniolo P, Weijenberg MP, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Hunter DJ.

Cancer Causes Control. 2010 Nov;21(11):1919-30. doi: 10.1007/s10552-010-9620-8. Epub 2010 Sep 5.

35.

Human chorionic gonadotropin in pregnancy and maternal risk of breast cancer.

Toniolo P, Grankvist K, Wulff M, Chen T, Johansson R, Schock H, Lenner P, Hallmans G, Lehtinen M, Kaaks R, Wadell G, Zeleniuch-Jacquotte A, Lundin E, Lukanova A.

Cancer Res. 2010 Sep 1;70(17):6779-86. doi: 10.1158/0008-5472.CAN-09-4622. Epub 2010 Aug 16.

36.

Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations.

Barekati Z, Radpour R, Kohler C, Zhang B, Toniolo P, Lenner P, Lv Q, Zheng H, Zhong XY.

Hum Mol Genet. 2010 Aug 1;19(15):2936-46. doi: 10.1093/hmg/ddq199. Epub 2010 May 12.

PMID:
20466735
37.

Maternal hormones during early pregnancy: a cross-sectional study.

Chen T, Lundin E, Grankvist K, Zeleniuch-Jacquotte A, Wulff M, Afanasyeva Y, Schock H, Johansson R, Lenner P, Hallmans G, Wadell G, Toniolo P, Lukanova A.

Cancer Causes Control. 2010 May;21(5):719-27. doi: 10.1007/s10552-009-9500-2. Epub 2010 Jan 19.

38.

IGF-I during primiparous pregnancy and maternal risk of breast cancer.

Chen T, Lukanova A, Grankvist K, Zeleniuch-Jacquotte A, Wulff M, Johansson R, Schock H, Lenner P, Hallmans G, Wadell G, Toniolo P, Lundin E.

Breast Cancer Res Treat. 2010 May;121(1):169-75. doi: 10.1007/s10549-009-0519-6. Epub 2009 Sep 2.

39.

Circulating vitamin d and risk of epithelial ovarian cancer.

Arslan AA, Clendenen TV, Koenig KL, Hultdin J, Enquist K, Agren A, Lukanova A, Sjodin H, Zeleniuch-Jacquotte A, Shore RE, Hallmans G, Toniolo P, Lundin E.

J Oncol. 2009;2009:672492. doi: 10.1155/2009/672492. Epub 2009 Aug 27.

40.

Serum 25-hydroxyvitamin D and the risk of ovarian cancer.

Toriola AT, Surcel HM, Agborsangaya C, Grankvist K, Tuohimaa P, Toniolo P, Lukanova A, Pukkala E, Lehtinen M.

Eur J Cancer. 2010 Jan;46(2):364-9. doi: 10.1016/j.ejca.2009.08.002. Epub 2009 Aug 25.

PMID:
19713101
41.

Circulating estrogen metabolites and risk for breast cancer in premenopausal women.

Arslan AA, Shore RE, Afanasyeva Y, Koenig KL, Toniolo P, Zeleniuch-Jacquotte A.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2273-9. doi: 10.1158/1055-9965.EPI-09-0312.

42.

C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy).

Lundin E, Dossus L, Clendenen T, Krogh V, Grankvist K, Wulff M, Sieri S, Arslan AA, Lenner P, Berrino F, Hallmans G, Zeleniuch-Jacquotte A, Toniolo P, Lukanova A.

Cancer Causes Control. 2009 Sep;20(7):1151-9. doi: 10.1007/s10552-009-9330-2. Epub 2009 Mar 20.

43.

Reproducibility of serum cytokines and growth factors.

Gu Y, Zeleniuch-Jacquotte A, Linkov F, Koenig KL, Liu M, Velikokhatnaya L, Shore RE, Marrangoni A, Toniolo P, Lokshin AE, Arslan AA.

Cytokine. 2009 Jan;45(1):44-9. doi: 10.1016/j.cyto.2008.10.014. Epub 2008 Dec 5.

44.

Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study.

Lukanova A, Andersson R, Wulff M, Zeleniuch-Jacquotte A, Grankvist K, Dossus L, Afanasyeva Y, Johansson R, Arslan AA, Lenner P, Wadell G, Hallmans G, Toniolo P, Lundin E.

Am J Epidemiol. 2008 Dec 1;168(11):1284-91. doi: 10.1093/aje/kwn254. Epub 2008 Oct 20.

45.

Reproducibility of serum pituitary hormones in women.

Arslan AA, Gu Y, Zeleniuch-Jacquotte A, Koenig KL, Liu M, Velikokhatnaya L, Shore RE, Toniolo P, Linkov F, Lokshin AE.

Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):1880-3. doi: 10.1158/1055-9965.EPI-08-0103.

46.

Polymorphisms in RAD51, XRCC2, and XRCC3 are not related to breast cancer risk.

Brooks J, Shore RE, Zeleniuch-Jacquotte A, Currie D, Afanasyeva Y, Koenig KL, Arslan AA, Toniolo P, Wirgin I.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):1016-9. doi: 10.1158/1055-9965.EPI-08-0065. No abstract available.

47.

Re: C-reactive protein and risk of breast cancer.

Zeleniuch-Jacquotte A, Gu Y, Bruning PF, Bonfrer JM, Koenig KL, Arslan AA, Toniolo P, Shore RE.

J Natl Cancer Inst. 2008 Mar 19;100(6):443-4; author reply 444-5. doi: 10.1093/jnci/djn016. Epub 2008 Mar 11. No abstract available.

PMID:
18334713
48.

Polymorphisms in XPC and ERCC2 genes, smoking and breast cancer risk.

Shore RE, Zeleniuch-Jacquotte A, Currie D, Mohrenweiser H, Afanasyeva Y, Koenig KL, Arslan AA, Toniolo P, Wirgin I.

Int J Cancer. 2008 May 1;122(9):2101-5. doi: 10.1002/ijc.23361.

49.

Reliability of tumor markers, chemokines, and metastasis-related molecules in serum.

Linkov F, Gu Y, Arslan AA, Liu M, Shore RE, Velikokhatnaya L, Koenig KL, Toniolo P, Marrangoni A, Yurkovetsky Z, Zeleniuch-Jacquotte A, Lokshin AE.

Eur Cytokine Netw. 2009 Mar;20(1):21-6. doi: 10.1684/ecn.2009.0146.

50.

Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer.

Clendenen TV, Arslan AA, Koenig KL, Enquist K, Wirgin I, Agren A, Lukanova A, Sjodin H, Zeleniuch-Jacquotte A, Shore RE, Hallmans G, Toniolo P, Lundin E.

Cancer Lett. 2008 Feb 18;260(1-2):209-15.

Supplemental Content

Loading ...
Support Center